Lela M. Lucy

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +2

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma

S. Vincent Rajkumar, Laura Rosiñol, Mohamad A. Hussein et al. · Journal of Clinical Oncology · 2008 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Martin Kropff, H Baylon, Tadeusz Robak et al. · Haematologica · 2011 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (>30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial

John F. Seymour, Hartmut Döhner, Aleksandra Butrym et al. · Blood · 2014 · 14 citations

Medicine, Oncology, Pharmacotherapy +13